We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Study of Bavituximab and Sorafenib In Patients With Advanced Liver Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01264705
Recruitment Status : Active, not recruiting
First Posted : December 22, 2010
Last Update Posted : June 1, 2016
Information provided by (Responsible Party):
University of Texas Southwestern Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : December 2016
  Estimated Study Completion Date : December 2016